It is encouraging that many specific inhibitors such as NU7441, M3814, VX‐984, and AZD7648 can target DNA‐PKcs to reduce its kinase activity and control the development and progression of cancers from proliferation, differentiation, migration, and metabolism. The gene discussed is PRKDC; the disease is cancer.